Silibinin is a flavonoid, isolated from silybum marianum and the flavone luteolin, which downregulates the overexpression of the IGF-1 domain of the IGF-axis, leading to suppression of the growth and inhibition of the progression of tumors in prostate cancer [88,89,90]. The gene discussed is IGF1; the disease is prostate carcinoma.